Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases

Contraception

Volumn 76, Issue 1, 2007, Pages 35-39

  Vidin, Eric ^a   Garbin, Olivier ^a   Rodriguez, Brice ^a   Favre, Romain ^a   Bettahar Lebugle, Karima ^a  

^a SIHCUS CMCO Centre Medico Chirurgical et Obstetrical   (France)

Author keywords

Contraceptive implant; Difficult removal; Etonogestrel; Ultrasound guidance

Indexed keywords

ETONOGESTREL;

ARTICLE; BREAKTHROUGH BLEEDING; CASE STUDY; CLINICAL ARTICLE; CONTRACEPTION; DATA ANALYSIS; DEVICE REMOVAL; FEMALE; GENERAL ANESTHESIA; HUMAN; HUMERUS; LOCAL ANESTHESIA; NERVE SHEATH; OPERATING ROOM; PARESTHESIA; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SEROMA; ULNAR NERVE; UNIVERSITY HOSPITAL;

CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; FEMALE; FRANCE; HUMANS; MEDICAL RECORDS; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROGESTERONE CONGENERS; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34250672428     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2007.03.012     Document Type: Article

References (26)

1. Wenzl R., van Beek A., Schnabel P., and Huber J. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon®. Contraception 58 (1998) 283-288
2. Croxatto H.B., and Mäkäräinen L. The pharmacodynamics and efficacy of Implanon®. An overview of the data. Contraception 58 Suppl (1998) 91S-97S
3. Sergent F., Clamageran C., Bastard A.M., Verspyck E., and Marpeau L. Acceptabilité de l'implant contraceptif à l'étonogestrel (Implanon®). J Gynecol Obstet Biol Reprod 33 (2004) 407-415
4. Reuter S., and Smith A. Implanon®: user views in the first year across three family planning services in the Trent Region, UK. Eur J Contracept Reprod Health Care 8 (2003) 27-36
5. Cravioto M.C., Alvarado G., Canto-de-Cetina T., et al. A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant® and Norplant®-II. Contraception 55 (1997) 359-367
6. Affandi B., Korver T., Paul T., Geurts B., Coelingh H., and Benninck J.T. A pilot efficacy study with a single-rod contraceptive implant (Implanon®) in 200 Indonesian women treated for ≤4 years. Contraception 59 (1999) 167-174
7. Croxatto H.B., Urbancsek J., Massai R., Coelingh Benninck H., van Beek A., and and the Implanon® Study Group. A multicenter efficacy and safety study of the single contraceptive implant Implanon®. Hum Reprod 14 (1999) 976-981
8. Zheng S.R., Zheng H.M., Qian S.Z., Sang G.W., and Kaper R.F. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon®) and six-capsule (Norplant®) hormonal contraceptive implant. Contraception 60 (1999) 1-8
9. Sarma SP., and Wamsher JG. Removal of deeply inserted, nonpalpable levonogestrel (Norplant®) implants. Contraception 53 (1996) 159-161
10. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon®. Contraception 58 Suppl (1998) 99S-107S
11. Graesslin O., Hoffet M., Barjot P., et al. Le suivi à long terme d'une cohorte de femmes porteuses d'un implant contraceptif (Implanon®): analyse intermédiaire de données de l'observatoire de l'OPNI. Gynecol Obstet Fertil 33 (2005) 315-321
12. Urbanscek J. An integrated analysis of nonmenstrual adverse events with Implanon®. Contraception 58 Suppl (1998) 109S-115S
13. Bitzer J., Tschudin J., Alder J., and and the Swiss Implanon Study Group. Acceptability and side-effects of Implanon in Switzerland: a retrospective study by the Implanon Swiss Study Group. Eur J Contracept Reprod Health Care 9 (2004) 278-284
14. Darney P.D., Klaisle C., and Walker D.M. The "pop out" method of Norplant removal. Adv Contracept 8 (1992) 188-189
15. Mascarenhas L. Insertion and removal of Implanon®. Contraception 58 Suppl (1998) 79S-83S
16. Bensouda-Grimaldi L., Jonville-Béra A.P., Beau-Salinas F., Llabres S., Autret-Leca E., and le réseau des centres régionaux de pharmacovigilance. Insertion problems, removal problems, and contraception failures with Implanon®. Gynecol Obstet Fertil 33 (2005) 986-990
17. Twickler D.M., and Schwarz B.E. Imaging of the levonorgestrel implantable contraceptive device. Am J Obstet Gynecol 167 (1992) 572-573
18. Lantz A., Nosher J.L., Pasquale S., and Siegel R.L. Ultrasound characteristics of subdermally implanted Implanon™ contraceptive rods. Contraception 56 (1997) 323-327
19. Amman P., Botta U., Montet X., and Bianchi S. Sonographic detection and localization of a clinically nondetectable subcutaneous contraceptive implant. J Ultrasound Med 22 (2003) 855-859
20. Merki-Feld G., Brekenfeld C., Migge B., and Keller P.J. Nonpalpable ultrasonographically not detectable Implanon rods can be localized by MR imaging. Contraception 63 (2001) 325-328
21. Westerway S.C., Picker R., and Christie J. Implanon implant detection with ultrasound and magnetic resonance imaging. Aust N Z J Obstet Gynaecol 43 (2003) 346-350
22. Hatasaka H. Implantable levonorgestrel contraception: 4 years of experience with Norplant. Clin Obst Gynecol 38 (1995) 859-871
23. Oloto E., and Bromham D. Norplant removal: a review. Br J Fam Plann 21 Suppl (1995) 21-24
24. Sicot C. Responsabilité civile professionnelle: rapport du conseil médical du Sou Médical - Groupe MACSF sur l'exercice 2003. Responsabilité 11 (2004) 3-24
25. Sicot C. Responsabilité civile professionnelle: rapport du conseil médical du Sou Médical - Groupe MACSF sur l'exercice 2004. Responsabilité 3 (2005) 3-27
26. Rai K., Gupta S., and Cotter S. Experience with Implanon in a northeast London family planning clinic. Eur J Contracept Reprod Health Care 9 (2004) 39-46